(3 years ago)
Lords ChamberThe noble Lord raises a very important concern about e-cigarettes. From conversations I have had with the MHRA and others, I understand that, at the moment, there is no evidence in the UK that young non-smokers are adopting or taking up smoking e-cigarettes. Most users of e-cigarettes use them as a pathway away from cigarettes.
My Lords, to follow up on that point, e-cigarettes are sold using flavours such as dragon berry, bubblegum, gummy bears and unicorn juice, in colourful packaging with cartoon characters—all clearly aimed at children. If we are considering licensing e-cigarettes, could this also be an opportunity to tighten up the packaging and branding rules to ensure that that stops?
There are a number of factors that will be looked at when licensing e-cigarettes, including incentives to customers—flavours, et cetera—to take up these products. I will have a discussion with the MHRA to ask that question in more detail, if the noble Lord would like to write to me.
(3 years, 10 months ago)
Lords ChamberThe central proposition we are discussing is that it is better to double the number of people getting their first jab, even if there is a marginal decrease in the efficacy of the vaccine for a few people. That message has got through to the public and I think it enjoys tremendous public support. I acknowledge the concern that some will naturally feel about what appears to be a diminution in provision, but I am here to reassure and provide consistent scientific advice that is not the case.
My Lords, two logistical questions are raised by delaying second doses. First, given AstraZeneca’s statement yesterday about variability of manufacture, together with the increasing global demand going forward, how will the Government guarantee we have enough vaccines of the right type for all second doses at 12 weeks? Secondly, am I right that from the end of March the rate of new vaccinations will fall sharply, because we will then need 2 million doses per week just to cover the second doses?
I think the noble Lord has read too much into the AstraZeneca statement. Negotiations with AstraZeneca and provisions in manufacturing capacity are extremely well advanced. All the projections in the vaccine plan published yesterday have been bottomed out and secured with manufacturers and deployment. The Secretary of State was very clear about the objectives of 13.6 million by the end of February and the whole country by the autumn. Those are not vague reassurances; those are bottomed out and have business plans behind them.
(4 years, 10 months ago)
Lords ChamberMy Lords, the noble Baroness has mentioned that smoking among children is relatively low, but it is growing fast: it has more than doubled in the last four years. I strongly urge her to speak to schools. My own conversations suggest that in the last year and a half to two years it has increased more than fivefold. Does she agree that flavours such as gummy bear, twister lollipop, jelly babies, pixie tarts and unicorn milk are quite clearly aimed at children? It really is time that we looked at the rules around this.
The noble Lord is absolutely right: there must be no complacency when it comes to any kinds of illicit drugs or substances aimed at children. We have very active policies, led by the Home Office in partnership with the department of health, to ensure that we keep up with all these substances. On smoking and the use of e-cigarettes, my figures are slightly different from his, and I am very happy to discuss this with him after Questions.
(6 years ago)
Lords ChamberTo ask Her Majesty's Government whether they have any plans to restrict or ban the advertising or sale of flavoured nicotine vaping fluids.
I beg leave to ask the Question standing in my name on the Order Paper. In doing so, I declare that I hold shares in British American Tobacco, which are below the threshold for registration.
My Lords, strong controls are already in place. Vaping fluids containing nicotine are regulated through the Tobacco and Related Products Regulations 2016, which include measures to restrict their use by children. The nicotine inhaling products regulations 2015 make it illegal to sell such liquids to anyone under the age of 18. The Advertising Standards Authority includes a provision in its codes to ensure that advertisers do not target or feature children.
I thank the Minister for his Answer. However, the regulations do not seem to be working. Flavours include bubblegum, sherbet lemon, unicorn blood and strawberry delight, and come in colourful packaging with cartoon characters and pictures of sweets, for use with high-tech shiny gadgets. It would be hard to design something that was more appealing to children. According to recent tests, four in 10 retailers are willing to sell without age restrictions. In the US, the FDA says that underage use has surged recently and reached epidemic proportions. Does the Minister agree with the commissioner of the FDA, who said:
“I believe certain flavors are one of the principal drivers of the youth appeal of these products”?
Will he please look again at the rules and how they are enforced, just as the US is now doing aggressively, before we too have an epidemic of childhood nicotine addiction?
The FDA has certainly said that it is facing an epidemic of childhood use, but the numbers are quite stark in their difference. In America, many more young people use e-cigarettes compared to in this country, where only 2% of 11 to 18 year-olds are using once a week. Generally, those are young people who smoke already—around 7% of 15 year-olds smoke. America did not restrict tank sizes until recently, but we did; it did not restrict bottle sizes, but we did; it did not ban advertising, but we did; and it does not have restrictions on nicotine, but we do. We have a very sensible system. I am not complacent about the need to make sure that young people do not use, which we are not seeing yet, and there are severe restrictions and punishments for any retailer who sells such products to children.